Low-dose 4-factor PCC for urgent warfarin reversal

被引：0
|
作者：
Zemrak, W. [1 ]
Smith, K. [1 ]
Rolfe, S. [1 ]
Hayes, T. [2 ]
Trowbridge, R. [3 ]
Seder, D. [4 ]
机构：
[1] Maine Med Ctr, Pharm Serv, Portland, ME USA
[2] Maine Med Ctr, Pathol, Portland, ME USA
[3] Maine Med Ctr, Hosp Med, Portland, ME USA
[4] Maine Med Ctr, Crit Care Serv, Portland, ME USA
来源：
JOURNAL OF THROMBOSIS AND HAEMOSTASIS | 2015年 / 13卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PO367-WED
引用
收藏
页码：885 / 885
页数：1
相关论文
共 50 条
  • [31] EVALUATION OF AN INSTITUTIONAL FIXED-DOSE 4-FACTOR PCC PROTOCOL
    Housley, Cora
    Trujillo, Toby
    Kiser, Tyree
    Van Matre, Edward
    MacLaren, Robert
    Fish, Douglas
    Reynolds, Paul
    Mueller, Scott
    CRITICAL CARE MEDICINE, 2019, 47
  • [32] Rapid Reversal of Warfarin in Patients with Acute Major Bleeding by using an Initial Fixed Dose of 4-Factor PCCs
    Stein, A.
    Logdberg, L. E.
    Fayyaz, K.
    Bank, M.
    Rosenberg, D. J.
    Lee, D. C.
    Kapinos, G.
    Cohen, J.
    Shafeeq, H.
    Chhibber, V.
    TRANSFUSION, 2015, 55 : 172A - 172A
  • [33] COMPARISON OF 4-FACTOR PROTHROMBIN COMPLEX CONCENTRATE DOSING STRATEGIES FOR WARFARIN REVERSAL
    Rivosecchi, Ryan
    Dibridge, Julie
    CRITICAL CARE MEDICINE, 2021, 49 (01) : 417 - 417
  • [34] ANDEXANET ALFA VERSUS 4-FACTOR PCC FOR REVERSAL OF INTRACRANIAL HEMORRHAGE ASSOCIATED WITH FACTOR XA
    Semon, Gregory
    Straughn, Angela
    Hardman, Claire
    Steel, Barbara
    Ekeh, Akpofure
    CRITICAL CARE MEDICINE, 2021, 49 (01) : 301 - 301
  • [35] Retrospective study of rFVIIa, 4-factor PCC, and a rFVIIa and 3-factor PCC combination in improving bleeding outcomes in the warfarin and non-warfarin patient
    DeLoughery, Emma
    Avery, Brian
    DeLoughery, Thomas G.
    AMERICAN JOURNAL OF HEMATOLOGY, 2016, 91 (07) : 705 - 708
  • [36] Tolerability and effectiveness of 4-factor prothrombin complex concentrate (4F-PCC) for warfarin and non-warfarin reversals
    Santibanez, M.
    Lesch, C. A.
    Lin, L.
    Berger, K.
    JOURNAL OF CRITICAL CARE, 2018, 48 : 183 - 190
  • [37] EFFECT OF 4-FACTOR PCC REVERSAL PROTOCOL IN LVAD PATIENTS UNDERGOING HEART TRANSPLANTATION
    Wong, Man-Ching
    Mak, Hannah
    Ferreira, Renata
    CRITICAL CARE MEDICINE, 2019, 47
  • [38] CASE SERIES OF FIXED LOW-DOSE RECOMBINANT FACTOR VII FOR WARFARIN REVERSAL IN NEUROSURGICAL PATIENTS
    Blank, Gregory
    Harris, Serena
    Vandenberg, Melissa
    McAllen, Karen
    CRITICAL CARE MEDICINE, 2012, 40 (12) : U340 - U340
  • [39] Reversal of Warfarin-Associated Life-Threatening Bleed With an Attenuated Dose of 4-Factor Prothrombin Complex Concentrate
    Wexler, Allyson H.
    Rech, Megan A.
    ANNALS OF PHARMACOTHERAPY, 2018, 52 (02) : 212 - 213
  • [40] Comparison of 3-Factor Prothrombin Complex Concentrate and Low-Dose Recombinant Factor VIIa for Warfarin Reversal
    Scott A Chapman
    Eric D Irwin
    Nada M Abou-Karam
    Nichole M Rupnow
    Katherine E Hutson
    Jeffrey Vespa
    Robert M Roach
    World Journal of Emergency Surgery, 9
12345